Morphodrive By MN Morphogen Nutrition Overview & Drug Interactions

Check For Interactions With Morphodrive

Supplement: Morphodrive by MN Morphogen Nutrition

Morphodrive Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Morphodrive by MN Morphogen Nutrition

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
6 Capsule(s)
Maximum serving Sizes:
6 Capsule(s)
Servings per container 30
UPC/BARCODE 644216079872

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Bitter melon extract
1500 mg
Bitter Melon
Gymnema sylvestre Leaf Extract
1000 mg
Gymnema
Cinnamon bark extract
500 mg
Cinnamon
Fenugreek extract
500 mg
Fenugreek
Banaba Leaf Extract
250 mg
banaba
AstraGin
50 mg
Proprietary Blend (Herb/Botanical)
Chromium
200 mcg
Chromium 167%
Alpha-Galactosidase
0 NP
Alpha Galactosidase
Amylase
0 NP
Amylase
Cellulase
0 NP
Cellulase
Glucoamylase
0 NP
Glucoamylase
Invertase
0 NP
Sucrase
Lactase
0 NP
Lactase
Maltase
0 NP
Maltase
Pectinase
0 NP
Pectinase
Xylanase
0 NP
Xylanase

Other Ingredients:
Gelatin
Titanium Dioxide
Candurin Silver Fine
FD&C Yellow #6
FD&C Blue #1
FD&C Red #40


Label Statments:


Suggested/Recommended/Usage/Directions
- Recommended use: Take 6 capsules per day with carbohydrate containing meals. Dose can be taken all at once with biggest meal of the day or divided up amongst carbohydrate containing meals. Exceeding recommended daily dose is not advised.
Precautions
- Exceeding recommended daily dose is not advised.
- Warnings: Not intended for use by persons under the age of 18.
- If you are pregnant or nursing or are taking any prescription medications, consult your health care professional before using this or any other dietary supplement product.
- Immediately discontinue use and consult your doctor if any adverse reactions occur.
- Keep out of reach of children.
Storage
- Store in a cool, dry place and avoid excessive heat.
Brand IP Statement(s)
- AstraGin is a registered trademark of NuLiv Science. Chromax is a registered trademark of Nutrition 21 and is licensed under U.S. Patent #6,329,361.
Formulation
- Nutrient partitioning Agent Uptake Insulin Sensitivity Digestion
- May assist with: Increasing insulin sensitivity Carbohydrate digestion, uptake, and deposition Nutrient absorption Blood sugar control Decreasing inflammation
Formula
- With: AstraGin Chromax chromium picolinate
FDA Statement of Identity
- Dietary Supplement
General Statements
- Morphogen Nutrition specializes in developing no BS, scientifically validated, effectively dosed and affordable sports nutrition supplements Knowledge Honesty Integrity No BS High Potency Formula Pure Ingredients Maximum Performance
- Join the takeover
FDA Disclaimer Statement
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Seals/Symbols
- Manufactured in the USA for Morphogen Nutrition GMP Good Manufacturing Practice Quality Product FDA Registered Lab Tested 3rd Party Certified for Purity & Potency

Brand Information

See all products by this brand

Manufacturer
Name Morphogen Nutrition
Web Address www.mntakeover.com

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.